Literature DB >> 11556302

Changing the status of drugs from prescription to over-the-counter availability.

E P Brass1.   

Abstract

The availability of drugs on an over-the-counter basis, including those previously available only by prescription, provides patients with improved access to effective therapies. Removal of the requirement for prescriptions saves both the health care professional and the patient time. However, the overall effect on health care costs is complex. One such effect may be that costs shift from third-party payers to patients. In addition, short-term cost savings may be offset over the long term by problems due to inappropriate use or suboptimal therapy. Optimal therapy with an over-the-counter drug requires that the consumer diagnose the underlying condition correctly and use the drug in a manner that minimizes risk. Assessment of the ability of patients to use drugs in this manner is a critical component of the regulatory review of over-the-counter drugs. The available data arouse the concern that without the supervision of a health care professional, some patients may not be able to use over-the-counter drugs appropriately for certain diagnoses or chronic conditions or in high-risk situations. On the other hand, the widespread use of over-the-counter aspirin on a long-term basis for cardiovascular-risk reduction illustrates the potential value of increased drug availability for long-term therapy. Advances in technology may facilitate the growth of over-the-counter drug therapy. For example, the wide availability and acceptance of reliable methods for measuring serum cholesterol in nonmedical settings may eventually contribute to the safety and effectiveness of over-the-counter treatments for hyperlipidemia. Thus, the future promises increases in the number of drugs available over the counter and in the variety of indications for their use.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11556302     DOI: 10.1056/NEJMra011080

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  34 in total

1.  Persistent use of nicotine replacement therapy: an analysis of actual purchase patterns in a population based sample.

Authors:  S Shiffman; J R Hughes; J L Pillitteri; S L Burton
Journal:  Tob Control       Date:  2003-09       Impact factor: 7.552

2.  Consumer knowledge of over-the-counter phenazopyridine.

Authors:  Chih-Wen Shi; Steven M Asch; Eve Fielder; Lillian Gelberg; Michael B Nichol
Journal:  Ann Fam Med       Date:  2004 May-Jun       Impact factor: 5.166

3.  How removing prescription drugs from reimbursement lists increases the pharmaceutical expenditures for alternatives.

Authors:  Ozden Gür Ali; Başak Topaler
Journal:  Eur J Health Econ       Date:  2010-08-18

Review 4.  Should cholesterol-lowering medications be available in Canada without a prescription?

Authors:  Shirya Rashid
Journal:  Can J Cardiol       Date:  2007-03-01       Impact factor: 5.223

5.  Adjudicating rights or analyzing interests: ethicists' role in the debate over conscience in clinical practice.

Authors:  Armand H Matheny Antommaria
Journal:  Theor Med Bioeth       Date:  2008

6.  Safety of non-prescription medicines: knowledge and attitudes of Italian pharmacy customers.

Authors:  Laura Cuzzolin; Giuseppina Benoni
Journal:  Pharm World Sci       Date:  2009-11-18

7.  From prescription-only (Rx) to over-the-counter (OTC) status in Germany 2006-2015: pharmacological perspectives on regulatory decisions.

Authors:  Eva Barrenberg; Edeltraut Garbe
Journal:  Eur J Clin Pharmacol       Date:  2017-03-28       Impact factor: 2.953

8.  Results of a national survey on over-the-counter medicines, Part 1: Pharmacist opinion on current scheduling status.

Authors:  Jeff Taylor; Eric Landry; Lyne Lalonde; Ross T Tsuyuki
Journal:  Can Pharm J (Ott)       Date:  2012-01

9.  Prescription and nonprescription drug use in isfahan, Iran: An observational, cross-sectional study.

Authors:  Amir H Zargarzadeh; Mohsen Minaeiyan; Amir Torabi
Journal:  Curr Ther Res Clin Exp       Date:  2008-02

Review 10.  Implications of a switch from prescription to over-the-counter status for allergy drugs.

Authors:  Eric P Brass
Journal:  Curr Allergy Asthma Rep       Date:  2004-05       Impact factor: 4.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.